EUVIMEDEUVIMED entdecken
Crossref

Prevalence, Predictors, and Cross-Resistance of Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacterales in Pediatric Urinary Tract Infections in Israel

Suha Rizik, Imad Kassis, Elias Nasrallah, Nadeen Makhoul, Halima Dabaja-Younis iD

Clinical Pediatrics · 2024-12 · 63 (12) · 1727-1733

DOI: 10.1177/00099228241241932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pediatrics, online erschienen am 29.03.2024. Verfasst von Suha Rizik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Ruth Rappaport Children's Hospital, Haifa, Israel. Hauptthemen laut MEDLINE: Urinary Tract Infections, Community-Acquired Infections, Enterobacteriaceae Infections, beta-Lactamases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study evaluates the incidence and risk factors of community-acquired urinary tract infections (CA-UTIs) linked to extended-spectrum beta-lactamase–producing Enterobacterales (ESBLPE). The study was conducted in a tertiary hospital in northern Israel and included children younger than 18 years with CA-UTIs due to Enterobacterales who were admitted to the emergency department, during the years 2017 to 2019. Among the 570 children, 9.8% had ESBLPE-associated CA-UTIs. This prevalence remained steady over the study period. ESBLPE exhibited substantial resistance to amoxicillin/clavulanic acid (62.5% vs 20.4%, P < .001, odds ratio [OR] = 6.5), trimethoprim/sulfamethoxazole (58.9% vs 18%, P < .001, OR = 6.6), ciprofloxacin (33.9% vs 3.1%, P < .001, OR = 15.9), piperacillin/tazobactam (26.8% vs 7%, P < .001, OR = 4.9), and gentamicin (21.4% vs 4.3%, P < .001, OR = 6.1), compared with non-ESBLPE. Risk factors for ESBLPE-associated UTIs included recent antibiotic treatment within the past 3 months ( P = .003, OR = 3.5) and colonization with ESBLPE ( P < .001, OR = 12.8). Given the variable incidence of ESBLPE, relying on local epidemiology for antibiotic selection pending culture results is crucial. The study finding of a low ESBLPE incidence, coupled with global concerns regarding carbapenem resistance, supports cautious use of broad-spectrum antibiotics in nonsevere cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsCommunity-Acquired InfectionsEnterobacteriaceae Infectionsbeta-LactamasesHumansIsraelFemaleRetrospective StudiesMalePrevalenceChildChild, PreschoolInfantRisk FactorsEnterobacteriaceaeAnti-Bacterial AgentsAdolescent

Stichwörter der Autor:innen

ESBLEnterobacteraleschildrenpediatricurinary tract infection

Substanzen

beta-LactamasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Pediatric Department, Ruth Rappaport Children's Hospital, Haifa, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Pediatric Infectious Diseases Unit, Ruth Rappaport Children's Hospital, Haifa, Israel.

ORCID-Profile: Halima Dabaja-Younis

Zitieren

APA

Rizik, S., Kassis, I., Nasrallah, E., Makhoul, N., & Dabaja-Younis, H. (2024). Prevalence, Predictors, and Cross-Resistance of Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacterales in Pediatric Urinary Tract Infections in Israel. Clinical Pediatrics, 63(12), 1727-1733. https://doi.org/10.1177/00099228241241932

Vancouver

Rizik S, Kassis I, Nasrallah E, Makhoul N, Dabaja-Younis H. Prevalence, Predictors, and Cross-Resistance of Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacterales in Pediatric Urinary Tract Infections in Israel. Clinical Pediatrics. 2024;63(12):1727-1733. doi:10.1177/00099228241241932

BibTeX
@article{Rizik2024,
  author = {Rizik, Suha and Kassis, Imad and Nasrallah, Elias and Makhoul, Nadeen and Dabaja-Younis, Halima},
  title = {Prevalence, Predictors, and Cross-Resistance of Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacterales in Pediatric Urinary Tract Infections in Israel},
  journal = {Clinical Pediatrics},
  year = {2024},
  volume = {63},
  number = {12},
  pages = {1727--1733},
  doi = {10.1177/00099228241241932}
}
Kostenlos starten →